These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14101059)

  • 1. [INDICATIONS AND LIMITATIONS OF SPLENECTOMY IN THE TREATMENT OF THALASSEMIA MAJOR. CONSIDERATIONS ON 17 CASES].
    NICOLA P; D OLEGGIO AV; MOROSINI FIANDINO G
    Minerva Pediatr; 1963 Oct; 15():1047-56. PubMed ID: 14101059
    [No Abstract]   [Full Text] [Related]  

  • 2. POSTSPLENECTOMY INFECTION IN COOLEY'S ANEMIA.
    SMITH CH; ERLANDSON ME; STERN G; HILGARTNER MW
    Ann N Y Acad Sci; 1964 Oct; 119():748-57. PubMed ID: 14219454
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE BEHAVIOR OF THE LIFE-SPAN OF THE ERYTHROCYTES AND SOME INDEXES OF ERYTHROPOIESIS MEASURED WITH CR-51 IN SUBJECTS WITH THALASSEMIA MAJOR AND THALASSO-DREPANOCYTIC ANEMIA, BEFORE AND AFTER SPLENECTOMY].
    PRIOLISI A; GIUFFRE L
    Pediatria (Napoli); 1964 Apr; 72():266-82. PubMed ID: 14151462
    [No Abstract]   [Full Text] [Related]  

  • 4. [IRON EXCHANGE IN VARIOUS ANEMIC-HEMOLYTIC CONSTITUTIONAL BLOOD DISEASE: THALASSEMIA MAJOR, ELLIPTOCYTIC ANEMIA].
    SCHETTINI F
    Pediatria (Napoli); 1964; 72():29-38. PubMed ID: 14163249
    [No Abstract]   [Full Text] [Related]  

  • 5. ERYTHROCYTE LIFE-SPAN AND SITES OF DESTRUCTION IN THALASSEMIA MAJOR. RELATION TO CLINICAL AND LABORATORY FINDINGS.
    SITARZ AL; ULTMANN JE; WOLFF JA
    Acta Haematol; 1963; 30():204-14. PubMed ID: 14107559
    [No Abstract]   [Full Text] [Related]  

  • 6. [Partial splenectomy in thalassemia major. Apropos of 19 cases].
    Kehila M; Khelif A; Kharrat H; Ennabli S; Abderrahim T
    J Chir (Paris); 1994 Feb; 131(2):99-103. PubMed ID: 8207104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SURGICAL PROBLEMS IN SPLENECTOMY FOR COOLEY'S ANEMIA.
    FICARRA BJ
    Ann N Y Acad Sci; 1964 Oct; 119():722-6. PubMed ID: 14219451
    [No Abstract]   [Full Text] [Related]  

  • 8. RELATIONSHIP OF ERYTHROCYTE SURVIVAL AND RETICULOCYTE LEVELS TO SPLENECTOMY AND NEED FOR TRANSFUSION IN THALASSEMIA MAJOR.
    WOLFF JA; ULTMANN JE; SITARZ A
    Ann N Y Acad Sci; 1964 Oct; 119():686-93. PubMed ID: 14219447
    [No Abstract]   [Full Text] [Related]  

  • 9. [QUANTITATIVE EVALUATION OF HEMOLYSIS AND STUDY OF THE SITES OF HEMOCATHERESIS IN SOME SUBJECTS WITH THALASSEMIA MAJOR].
    PRIOLISI A; GIUFFRE L
    Pediatria (Napoli); 1963; 71():831-57. PubMed ID: 14125492
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peculiarities of iron metabolism in patients with Beta - thalassemia at different periods after splenectomy].
    Kadimova E
    Georgian Med News; 2007 Nov; (152):35-7. PubMed ID: 18175831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron studies of thalassaemic erythrocytes after splenectomy.
    Malamos B; Gyftaki E; Proukakis C; Poulios N
    Nature; 1965 Aug; 207(999):872-3. PubMed ID: 5885954
    [No Abstract]   [Full Text] [Related]  

  • 12. IN VITRO HEME SYNTHESIS BY HUMAN BLOOD: ABNORMAL HEME SYNTHESIS IN THALASSEMIA MAJOR.
    VAVRA JD; MAYER VK; MOORE CV
    J Lab Clin Med; 1964 May; 63():736-53. PubMed ID: 14158058
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up.
    Casale M; Cinque P; Ricchi P; Costantini S; Spasiano A; Prossomariti L; Minelli S; Frega V; Filosa A
    Eur J Haematol; 2013 Jul; 91(1):69-73. PubMed ID: 23581970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of splenectomy on the antibody response and serum protein pattern in subjects with thalassemia major].
    PRIOLISI A; GIUFFRE L
    Pediatria (Napoli); 1962; 70():753-78. PubMed ID: 13986245
    [No Abstract]   [Full Text] [Related]  

  • 15. THE METABOLISM OF THE INDIVIDUAL C14 LABELED HEMOGLOBINS IN PATIENTS WITH H-THALASSEMIA, WITH OBSERVATIONS ON RADIOCHROMATE BINDING TO THE HEMOGLOBINS DURING RED CELL SURVIVAL.
    GABUZDA TG; NATHAN DG; GARDNER FH
    J Clin Invest; 1965 Feb; 44(2):315-25. PubMed ID: 14260170
    [No Abstract]   [Full Text] [Related]  

  • 16. Portal vein thrombosis after splenectomy for beta-thalassemia major.
    Al-Hawsawi ZM; Haouimi AS; Hassan RA; Tarawah AM
    Saudi Med J; 2004 Feb; 25(2):225-8. PubMed ID: 14968225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMPARISON OF SIXTY-SIX PATIENTS WITH THALASSEMIA MAJOR AND THIRTEEN PATIENTS WITH THALASSEMIA INTERMEDIA: INCLUDING EVALUATIONS OF GROWTH, DEVELOPMENT, MATURATION AND PROGNOSIS.
    ERLANDSON ME; BRILLIANT R; SMITH CH
    Ann N Y Acad Sci; 1964 Oct; 119():727-35. PubMed ID: 14219452
    [No Abstract]   [Full Text] [Related]  

  • 18. Splenectomy, iron overload and liver cirrhosis in beta-thalassemia major.
    Okon E; Levij IS; Rachmilewitz EA
    Acta Haematol; 1976; 56(3):142-50. PubMed ID: 826069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and results for splenectomy for beta thalassemia in two hundred and twenty-one pediatric patients.
    Pinna AD; Argiolu F; Marongiu L; Pinna DC
    Surg Gynecol Obstet; 1988 Aug; 167(2):109-13. PubMed ID: 3400027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of portal vein thrombosis in patients with beta thalassemia major after splenectomy: laparoscopic versus open procedure.
    Wang M; Zhang M; Li J; Zhou J; Wu Z; Peng B
    Hepatogastroenterology; 2014; 61(129):48-54. PubMed ID: 24895792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.